The Epoch Times By  andÂ
Company says substandard results of COVID-19 vaccine trial expected
Regulators in the United States and elsewhere should not clear Modernaâs COVID-19 vaccine for children based on a clinical trial that found the shot under 50 percent effective in preventing infection, experts say.
Moderna is pushing for emergency authorization from the U.S. Food and Drug Administration (FDA) for its jab for kids as young as 6 months of age, based on the results of the trial.
The decision to authorize would mean some 20 million of the youngest children in America could get a COVID-19 vaccine for the first time since the pandemic started.
Some parents and experts want that to happen sooner rather than later and are willing to accept less than ideal results. But others arenât convinced that most of the age group needs a vaccine, especially a shot that doesnât perform well against emerging variants.
